Virtual Reality Cognitive Therapy for Mild Cognitive Impairment and Early Alzheimer’s
Official title: Virtual Reality Cognitive Therapy for MCI and Alzheimer's disease
Funded at Claritytek, INC. · NIH-11419322 · Data updated 2026-11-12
A home-use virtual reality program helps people with mild cognitive impairment or early Alzheimer’s disease practice everyday skills to use in real life.
Quick facts
| Grant type | Sbir 2 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Claritytek, INC. NIH-funded |
| Lab location | 1 site (Blaine, United States) |
| Project start | September 22, 2026 |
| Project end | May 31, 2029 |
| Funding year | 2026 |
| Award (this year) | $888,819 |
| NIH project number | 1R44AG099523-01A1 |
| Project ID | NIH-11419322 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates are adults with Mild Cognitive Impairment or early Alzheimer’s disease who can use home-based VR and have a caregiver or support system.
✕Less likely to help
Patients with advanced dementia or those unable to operate VR hardware may not benefit.
What this research studies
This project provides a home-based VR program that teaches compensatory strategies for everyday tasks and guides in-VR practice in calm scenes. It builds on prior feasibility work and will test a therapist-light version in a 20-week study with 128 participants. The study will measure daily living activities, cognitive status, and quality of life to see if the training helps real-world functioning.
Why it matters
Potential benefit: If successful, the program could offer a scalable non-pharmacologic option to support daily living for people with MCI or early Alzheimer’s.
How similar studies have gone: Prior feasibility data and evidence from related cognitive training support potential benefit, but this exact VR program is being tested in a larger, randomized trial.
Where this research is happening
-
Claritytek, INC.
Blaine, United States Active
Researchers
- Principal investigator: Masood, Razi — Claritytek, INC.
- Study coordinator: Masood, Razi
Related research
Other NIH-funded projects on the same topics.
-
DUET: a home VR-based program to support people with Alzheimer’s and their caregivers
A digital VR program called DUET helps people with Alzheimer's-related dementias and their caregivers stay mentally engaged and connected at home.
-
Understanding how brain activity changes may drive Alzheimer’s disease progression in a mouse model
Researchers are testing how changes in brain signals and protein cleanup processes affect the development of Alzheimer’s disease in mice.
-
Thiamine-boosting therapy for Alzheimer’s: understanding how benfotiamine may reduce harmful AGE in DP patients
A medication-based approach using high-dose vitamin B1 (benfotiamine) is studied to help people with Alzheimer's by reducing harmful sugar-related molecules.
-
Non-invasive tears biomarker for early Alzheimer's in LMICs
A low-cost, tear-based biomarker approach aims to detect early Alzheimer’s disease in older adults in Peru and similar settings.
-
Turning APOE4 into protective APOE2 or APOE3Christchurch to help with Alzheimer’s
A patient-facing explanation of a treatment idea that aims to change a genetic risk factor for Alzheimer's disease in the brain.
-
Telomerase in Alzheimer’s Disease: how aging biology could influence memory and brain health
Researchers are exploring a new brain-aging mechanism linked to telomerase, with potential to slow or modify Alzheimer’s disease in people and improve cognitive function.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.